Delivery Order SPE2DR25D9316-SPE2DR26FSCF2
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,966.25 to DMS Pharmaceutical Group Inc. for M-M-R II vaccine vials. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by September 12, 2025, and represents a routine procurement of immunization products for military and federal healthcare facilities....
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of M-M-R II vaccine vials. This $19.8K firm fixed-price delivery order was executed on August 4, 2025, with an ultimate completion date of August 7, 2025, and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected without a set-aside designation based on its...
- The Defense Logistics Agency awarded a delivery order valued at $2,373.04 to DMS Pharmaceutical Group Inc. for M-M-R II vaccine vials on September 25, 2025, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, is the awardee and has been registered in SAM.gov...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,299.10 for M-M-R II vaccine vials. The contract, issued on September 10, 2025, with an ultimate completion date of September 15, 2025, was funded by the Medical Supply Chain division of the Defense Logistics Agency. This delivery order was awarded without a set-aside designation, leveraging the company's competitive...
- This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,203.30 contract is for the delivery of M-M-R II vaccine vials, with a completion date of August 7, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,133.72 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a performance period through August 14, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- This federal contract award is a delivery order worth $2,373.04 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of M-M-R II vaccine vials to support the medical supply needs of military health facilities. The contract is a firm fixed-price delivery order with a completion date of February 28, 2025. DMS Pharmaceutical Group Inc. also holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,674.00 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a period of performance running through August 6, 2024. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $8,495.10 to supply 4562724754 M-M-R II vaccine vials to the Defense Logistics Agency. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to $5 million through December 2025. No set-aside designation was used for this award. DMS Pharmaceutical Group...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $4,152.75 and covers the delivery of M-M-R II vaccine vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of...
- SPE2DR25D9316Indefinite Delivery Contract
- SPE2DR25D9316-SPE2DR26FSCF2Delivery Order
The Defense Logistics Agency awarded a $37,400.93 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for M-M-R II vaccine vials. The delivery order, issued on January 30, 2026, with an ultimate completion date of February 2, 2026, carries no set-aside designation, indicating the company won the award through unrestricted federal procurement competition. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs for Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with demonstrated substantial contracting activity through the Defense Logistics Agency's Medical Supply Chain division. The company's comprehensive product portfolio spans branded and generic pharmaceuticals, biologics, vaccines, specialty medications, and medical consumables. The PPV-G GEN V contract, awarded in November 2025 with a ceiling value of $499,999,999 and an ultimate completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor capable of fulfilling the diverse and specialized pharmaceutical requirements of the federal military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.4k | 1/29/26 |